Financhill
Back

Exact Sciences 10K Form

Sell
46

EXAS
Exact Sciences

Last Price:
42.13
Seasonality Move:
7.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive EXAS News And Ratings

See the #1 stock for the next 7 days that we like better than EXAS

EXAS Financial Statistics

Sales & Book Value

Annual Sales: $2.5B
Cash Flow: $-119.96M
Price / Cash Flow: 0
Annual Sales: $17.04
Price / Book: 2.48

Profitability

EPS (TTM): -1.31570
Net Income (TTM): $-240.23M
Gross Margin: $1.85B
Return on Equity: -7.74%
Return on Assets: -3.76%

Exact Sciences Earnings Forecast

Key Exact Sciences Financial Ratios

  • The Gross Profit Margin over the past 26 years for EXAS is 73.83%.
  • The Selling, General & Administrative Expenses for EXAS have been equal to 64.82% of Gross Profit Margin.
  • The Research & Development expenses have been 17.04% of Revenue.
  • The Interest Expense is -11.96% of Operating Income.
  • The Net Earning history of EXAS is -8.17% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 14 years.

Exact Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EXAS
CUSIP: 30063P
Website: exactsciences.com

Debt

Debt-to-Equity Ratio: 0.76
Current Ratio: 1.64
Quick Ratio: 1.3

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 1283.97

EXAS Technical Analysis vs Fundamental Analysis

Sell
46
Exact Sciences (EXAS) is a Sell

Is Exact Sciences a Buy or a Sell?

  • Exact Sciences stock is rated a Sell
    The current Exact Sciences [EXAS] share price is $42.14. The Score for EXAS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.